Ryan Fukushima, Pathos AI CEO
May 2, 2025 10:55 AM EDT
Financing
Startups
AI

Pathos AI gets As­traZeneca fund­ing as biotech plans to raise up to $400M

Kyle LaHucik

Biotech Correspondent

Pathos AI, a Chica­go biotech led by ex­ec­u­tives of the health­care AI group Tem­pus, is look­ing at a fund­ing round of up …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump asks 'very tough hom­bre' Dr. Oz to lead MFN talks

About 5% of CBER and CDER left af­ter FDA staff cuts, analy­sis finds

US warns drug­mak­ers against mis­rep­re­sent­ing cost of im­port­ed prod­ucts

Merus’ Phase 2 over­all sur­vival da­ta reach ‘home run’ sce­nario — an­a­lyst

Ge­of­frey Porges ex­its Schrödinger with CFO swap; A new board seat for As­traZeneca's Pas­cal So­ri­ot

sponsored

Does your sup­ply chain hold up un­der pres­sure for high-risk tem­per­a­ture-crit­i­cal ship­ments?

A service from the Financial Times